Organovo Holdings, Inc.
ONVO
주식 순위
#36082
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
주가
$2.00
마지막 동기화: 2025-05-19
시가총액
$2.93M
변동 (1일)
-3.38%
변동 (1년)
656.14%
국가
US
거래 Organovo Holdings, Inc. (ONVO)
카테고리
Healthcare
의 시가총액 Organovo Holdings, Inc.(ONVO)
시가총액: $2.93M
October 2026 기준으로 Organovo Holdings, Inc.의 시가총액은 $2.93M입니다. 이는 당사 데이터에 따르면 Organovo Holdings, Inc.이 세계에서 36082nd번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2014부터 2026까지 Organovo Holdings, Inc.의 시가총액 기록
